SARAH SHRADER: Open Payments
NPI 1467157818 · NORFOLK, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,929 in 94 payments from 15 companies in 2025. Trend: 2023 $197 · 2024 $633 · 2025 $1,929
Food & beverage: $1,929
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $386 |
| Janssen Pharmaceuticals, Inc | 6 | $256 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $255 |
| Neurocrine BioSciences, Inc. | 14 | $226 |
| Alkermes, Inc. | 6 | $135 |
| E.R. Squibb & Sons, L.L.C. | 4 | $119 |
| Axsome Therapeutics, Inc. | 6 | $106 |
| Vanda Pharmaceuticals Inc. | 4 | $106 |
| Otsuka America Pharmaceutical, Inc. | 4 | $96 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $86 |
Products named: VRAYLAR, CAPLYTA, INGREZZA, SPRAVATO, REXULTI, ARISTADA, COBENFY, Auvelity.
Industry payments across VA — which companies pay providers there.
